NCT06783049Recruiting
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent System
Source: ClinicalTrials.gov · Last updated 21 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group). At one year, all patients will undergo face-to-face follow-up to assess clinical events, medication adherence, and the achievement of target risk factor levels.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 4490 (estimated)
- First submitted
- 14 Jan 2025
- Start date
- 3 Mar 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Beijing Tiantan Hospital
- Diseases
- Stroke
- NCT number
- NCT06783049
What you commit to
- Study type: Interventional
- Planned participants: 4490
- From 3 Mar 2025 to the primary completion date, 31 Dec 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients already enrolled in other stroke-related healthcare quality improvement projects or clinical trials.
Other
- Patients or family members who refuse to sign the informed consent form.
- Pregnant or breastfeeding women.
Who the study is looking for
- Age ≥ 18 years.
- Patients diagnosed with acute ischemic stroke or transient ischemic attack.
- Time from onset to enrollment ≤ 14 days.
- Presence of at least one modifiable risk factor (hypertension, diabetes).
- Ability to independently use a smartphone to complete system tasks upon discharge, or with the assistance of family members.
- Signed informed consent by the patient or their family members.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tsinghua Changgung Hospital Coordinator of this site? Confirm its status | Beijing | China | Active, not recruiting |
| Beijing Tiantan Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| The First Affiliated Hospital of Shihezi University Coordinator of this site? Confirm its status | Shihezi | China | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.